Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Seroconversion after anti-SARS-CoV-2 mRNA vaccinations among moderate-to-severe psoriatic patients receiving systemic biologicals-Prospective observational cohort study.
Piros ÉA, Cseprekál O, Görög A, Hidvégi B, Medvecz M, Szabó Z, Olajos F, Barabás E, Galajda N, Miheller P, Holló P. Piros ÉA, et al. Among authors: galajda n. Dermatol Ther. 2022 May;35(5):e15408. doi: 10.1111/dth.15408. Epub 2022 Mar 5. Dermatol Ther. 2022. PMID: 35218276 Free PMC article.
Deucravacitinib shows superior efficacy and safety in cutaneous lupus erythematosus compared to various biologics and small molecules - A systematic review and meta-analysis.
Bokor LA, Martyin K, Krebs M, Galajda NÁ, Meznerics FA, Szabó B, Hegyi P, Lőrincz K, Kiss N, Bánvölgyi A, Hidvégi B. Bokor LA, et al. Among authors: galajda na. Autoimmun Rev. 2024 Dec 16;24(3):103723. doi: 10.1016/j.autrev.2024.103723. Online ahead of print. Autoimmun Rev. 2024. PMID: 39694128 Free article. Review.
Safety and Efficacy Analysis of Targeted and Immune Combination Therapy in Advanced Melanoma-A Systematic Review and Network Meta-Analysis.
Lengyel AS, Meznerics FA, Galajda NÁ, Gede N, Kói T, Mohammed AA, Péter PN, Lakatos AI, Krebs M, Csupor D, Bánvölgyi A, Hegyi P, Holló P, Kemény LV. Lengyel AS, et al. Among authors: galajda na. Int J Mol Sci. 2024 Nov 28;25(23):12821. doi: 10.3390/ijms252312821. Int J Mol Sci. 2024. PMID: 39684531 Free PMC article. Review.
Reducing cardiovascular risk in immune-mediated inflammatory diseases: Tumour necrosis factor inhibitors compared to conventional therapies-A systematic review and meta-analysis.
Galajda NÁ, Meznerics FA, Mátrai P, Fehérvári P, Lengyel AS, Kolonics MV, Sipos Z, Kemény LV, Csupor D, Hegyi P, Bánvölgyi A, Holló P. Galajda NÁ, et al. J Eur Acad Dermatol Venereol. 2024 Jun;38(6):1070-1088. doi: 10.1111/jdv.19900. Epub 2024 Mar 3. J Eur Acad Dermatol Venereol. 2024. PMID: 38433519 Review.